CCCC

C4 Therapeutics, Inc

1 day chart

About CCCC

C4 Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on harnessing the body’s natural regulation of protein levels to develop therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. The Company provides technology platform, Target ORiented ProtEin Degrader Optimizer (TORPEDO), to synthesize a new class of small molecule protein degraders that are designed to destroy disease-causing proteins, including targets previously considered to be undruggable. The Company’s lead product candidates, CFT7455, is an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma (MM), peripheral T-cell lymphoma (PTCL), and mantle cell lymphoma (MCL). The Company is also developing CFT8634, an orally bioavailable degrader of a protein target called bromodomain containing 9 (BRD9), for synovial sarcoma and SMARCB1-deleted solid tumors.

Buy US stocks in Australia starting with CCCC. Open an account and start investing today!

Market Capitalisation

$164.36M

Price-earnings ratio

Dividend yield

0.00%

Volume

526

High today

$3.38

Low today

$3.13

Open price

$0.00

52-week high

$13.24

52-week low

$2.85

CCCC FAQs

Can I buy CCCC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CCCC shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of C4 Therapeutics, Inc?

One share of C4 Therapeutics, Inc is valued at $3.35.

What is the ticker symbol for C4 Therapeutics, Inc?

The ticker symbol for C4 Therapeutics, Inc is CCCC.

How do I buy CCCC shares in Australia?

To buy CCCC stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in CCCC

What is the 52-week high for C4 Therapeutics, Inc stock?

The C4 Therapeutics, Inc 52-week high stock price is $13.24.

What is the 52-week low for C4 Therapeutics, Inc stock?

The C4 Therapeutics, Inc 52-week low stock price is $2.85.

What is the market capitalisation of C4 Therapeutics, Inc CCCC?

As of 31/05/2023 C4 Therapeutics, Inc has a market cap of $164M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.